Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingnaojing for convulsive diseases in children
ChiCTR-TRC-08000097Phase 4Completed
- Sponsor
- Shenzhen Children's Hospital
- Start
- Jun 2008
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xingnaojing in febrile seizure (FS), epilepsy, cerebral palsy (CP) and 1 more (2 arms), sponsored by Shenzhen Children's Hospital. Primary endpoints: Antipyretic rate and Frequency of convulsive episodes. Started Jun 2008; status: completed.
02
Drugs
Xingnaojing
03
Conditions
febrile seizure (FS)epilepsycerebral palsy (CP)Convulsive disorders (also referred to as convulsion or convulsive seizure disorders)
Beyond the preview
Go deeper on ChiCTR-TRC-08000097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000097.